Fetal growth restriction
Conditions
Brief summary
Vaginal delivery; [yes/no]
Interventions
DRUGPROPESS 10 mg sistema de liberación vaginal
Sponsors
Hospital Universitario 12 De Octubre
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vaginal delivery; [yes/no] | — |
Countries
Spain
Outcome results
None listed